Skip to main content
Log in

Lysophosphatidylserine as histamine releaser in mice and rats

  • Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Lysophosphatidylserine is a specific inducer of histamine release in isolated mast cells. To determine whether a similar effect is manifestin vivo, the phospholipid was injected (1–5 mg/kg i.v.) into mice and rats. A dosedependent rise in blood histamine was observed in both animals. The several-fold increase in blood histamine occurred in the first minutes and was followed by a slower decline toward normal values. A second dose of lysophosphatidylserine was without effect. Systemic manifestations (depression, hypothermia, hypotension) were associated with the increased blood histamine level. When the tissue histamine stores accessible to lysophosphatidylserine were previously decreased by repeated phospholipid injections, no systemic symptoms occurred. Mobilization of carbohydrate reserves was also manifest during the action of lysophosphatidylserine. Prior treatment with compound 48/80 induced sustained refractoriness to lysophosphatidylserine. Structure-activity relationship demonstrated that the property to induce histamine release was linked to the structure of serine head group. Thus, other natural phospholipids or lysophospholipids were inactive. It is concluded that in analogy with the effect seenin vitro lysophosphatidylserine producesin vivo release of mast cell histamine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. Gregoriadis, The liposome drug-carrier concept: its development and future. InLiposomes in Biological Systems, pp. 25–86 (EdsG. Gregoriadis andA.C. Allison). J. Wiley, Chichester 1980.

    Google Scholar 

  2. A. Bruni andP. Palatini,Biological and pharmacological properties of phospholipids, Prog. Med. Chem.19, 111–203 (1982).

    Google Scholar 

  3. R. Fraley, S. Subramani, P. Berg andD. Papahadjopoulos,Introduction of liposomeencapsulated SV40 DNA into cells, J. biol Chem.255, 10431–10435 (1980).

    Google Scholar 

  4. A. Goth, H.R. Adams andM. Knoohuizen,Phosphatidylserine: selective enhancer of histamine release, Science, N.Y.173, 1034–1035 (1971).

    Google Scholar 

  5. I. Moodley, J.L. Mongar andJ.C. Foreman,Histamine release induced by dextran: the nature of the dextran receptor, Eur. J. Pharmac.83, 69–81 (1982).

    Google Scholar 

  6. E. Boarato, L. Mietto, G. Toffano, E. Bigon andA. Bruni,Different responses of rodent mast cells to lysophosphatidylserine Agents and Actions14, 613–618 (1984).

    Google Scholar 

  7. G. Toffano, A. Leon, S. Mazzari, G. Savoini, S. Teolato andP. Orlando,Modifications of noradrenergic hypothalamic system in rats injected with phosphatidylserine liposomes, Life Sci.23, 1093–1102 (1978).

    Google Scholar 

  8. G. Calderini, S. Teolato, A.C. Bonetti, A. Battistella andG. Toffano,Effect of lysophosphatidylserine on rat hypothalamic cyclic AMP in vivo, Life Sci.28, 2367–2375 (1981).

    Google Scholar 

  9. F. Casamenti, P. Mantovani, L. Amaducci andG. Pepeu,Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat, J. Neurochem.32, 529–533 (1979).

    Google Scholar 

  10. E. Bigon, E. Boarato, A. Bruni, A. Leon andG. Toffano,Pharmacological effects of phosphatidylserine liposomes: regulation of glycolisis and energy level in brain, Br. J. Pharmac.66, 167–174 (1979).

    Google Scholar 

  11. E. Bigon, E. Boarato, A. Bruni, A. Leon andG. Toffano,Pharmacological effects of phosphatidylserine liposomes: the role of lysophosphatidylserine, Br. J. Pharmac.67, 611–616 (1979).

    Google Scholar 

  12. A. Bruni, E. Bigon, G. Cappellazzo, E. Boarato, A. Leon andG. Toffano, Physiologic and pharmacologic implications in the deacylation of phosphatidylserine in mice. InAging of the Brain and Dementia, pp. 119–122 (EdsL. Amaducci, A.N. Davison andP.A. Antuono). Raven Press, New York 1980.

    Google Scholar 

  13. T.W. Martin andD. Lagunoff,Inhibition of mast cell histamine secretion by N-substituted derivatives of phosphatidylserine, Science, N.Y.204, 631–633 (1979).

    Google Scholar 

  14. T.W. Martin andD. Lagunoff,Interactions of lysophospholipids and mast cells, Nature, Lond.279, 250–252 (1979).

    Google Scholar 

  15. M.B. Lees,Preparation and analysis of phosphatides, Meth. Enzym.3, 328–345 (1957).

    Google Scholar 

  16. G.B. Ansell andJ.N. Hawthorne,Phospholipids. Chemistry, Metabolism and Function, B.B.A. Library, vol. 3, Elsevier, Amsterdam 1964.

    Google Scholar 

  17. S.E. Lindell andK. Viske,A note on the distribution of 14C-histamine added to blood, Br. J. Pharmac.17, 131–136 (1961).

    Google Scholar 

  18. W. Lorenz,Histamine release in man, Agents and Actions5, 402–416 (1975).

    Google Scholar 

  19. P.A. Shore, A. Burkhalter andV.H. Cohn,A method for the fluorimetric assay of histamine in tissues, J. Pharmac. exp. Ther.127, 182–186 (1959).

    Google Scholar 

  20. W. Lorenz, A. Schmal, H. Schult, S. Lang, C. Ohmann, D. Weber, B. Kapp, L. Lüben andA. Doenicke,Histamine release and hypotensive reactions in dog by solubilizing agents and fatty acids: analysis of various components in cremophor EL and development of a compound with reduced toxicity, Agents and Actions12, 64–80 (1982).

    Google Scholar 

  21. W.D.M. Paton,Histamine release by compounds of simple chemical structure, Pharmac. Rev.9, 269–328 (1957).

    Google Scholar 

  22. C. Atack,Measurement of biogenic amines using cation exchange chromatography and fluorimetric assay, Acta physiol. scand. Suppl.451, 28–38 (1977).

    Google Scholar 

  23. W. Lorenz, E. Matejka, A. Schmal, W. Seidel, H.J. Reimann, R. Uhlig andG. Mann,A phylogenetic study on the occurrence and distribution of histamine in the gastro-intestinal tract and other tissues of man and various animals, Comp. Gen. Pharmac.4, 229–250 (1973).

    Google Scholar 

  24. J.F. Riley, The location of histamine in the body, discussion byG.B. West. InCiba Foundation Symposium on Histamine, pp. 398–415 (EdsG.E.W. Wolstenholme andC.M. O'Connor). Churchill, London 1956.

    Google Scholar 

  25. M.A. Beaven andZ. Horakova,The enzymatic isotopic assay of histamine. InHandbook of Experimental Pharmacology, vol. XVIII, pp. 151–173 (EdsG.V.R. Born,O. Eichler,A. Farah,H. Herken andA.D. Welch). Springer-Verlag, Berlin 1978.

    Google Scholar 

  26. L. Aloe andR. Levi-Montalcini,Mast cell increase in tissue of neonatal rats injected with the nerve growth factor, Brain Res., Osaka133, 358–366 (1977).

    Google Scholar 

  27. V. Erspamer, Peripheral physiological and pharmacological actions of indolealkylamines. InHandbook of Experimental Pharmacology, vol. XIX, pp. 245–359 (EdsO. Eichler andA. Farah). Springer-Verlag, Berlin 1966.

    Google Scholar 

  28. G.A. Smith, T.R. Hesketh, R.W. Plumb andJ.C. Metcalfe,The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A, FEBS Letters105, 58–62 (1979).

    Google Scholar 

  29. A. Bruni, E. Bigon, E. Boarato, L. Mietto, A. Leon andG. Toffano,Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells, FEBS Letters138, 190–192 (1982).

    Google Scholar 

  30. Y. Stein andO. Stein,Metabolism of labelled lysolecithin, lysophosphatidylethanolamine and lecithin in the rat, Biochim. biophys. Acta464, 530–546 (1966).

    Google Scholar 

  31. L. Mietto, E. Boarato, G. Toffano, E. Bigon andA. Bruni,Local effects of lysophosphatidylserine in rats Agents and Actions14, 606–612 (1984).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruni, A., Bigon, E., Battistella, A. et al. Lysophosphatidylserine as histamine releaser in mice and rats. Agents and Actions 14, 619–625 (1984). https://doi.org/10.1007/BF01978896

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01978896

Keywords

Navigation